High cholesterol — clinically called hyperlipidemia or dyslipidemia (ICD-10 E78.5) — is one of the most common and most modifiable cardiovascular risk factors in the United States. According to the CDC (2024), about 94 million U.S. adults have a total cholesterol over 200 mg/dL, and roughly 28 million have levels over 240 mg/dL. The condition is typically silent until a heart attack or stroke makes itself known, so early identification through a simple blood test matters more than waiting for symptoms. A standard lipid panel reports four numbers: LDL cholesterol (often called "bad" cholesterol because it deposits in arteries), HDL cholesterol ("good" cholesterol because it carries cholesterol away from arteries), triglycerides, and total cholesterol. The American Heart Association's 2018 cholesterol guideline (ACC/AHA 2018) recommends a general LDL target below 100 mg/dL, with a stricter target below 70 mg/dL for adults at high cardiovascular risk. Viva Medical Center in Doral, FL runs cholesterol panels, calculates your individual 10-year cardiovascular risk, and builds a treatment plan — lifestyle first when numbers are borderline, with medication added when individual risk demands it — all in primary care, bilingual, and in-network with major carriers.
Understanding the Lipid Panel — LDL, HDL, Triglycerides
A complete lipid panel is a single blood draw, typically fasting for 9 to 12 hours, that produces four numbers. Knowing what each one means is the foundation of any conversation about your cardiovascular risk (National Heart, Lung, and Blood Institute — NHLBI, 2024).
- LDL cholesterol ("bad") — deposits in artery walls and drives plaque; target generally below 100 mg/dL, below 70 mg/dL in high-risk patients (AHA 2018)
- HDL cholesterol ("good") — carries cholesterol away from artery walls; target above 40 mg/dL for men, above 50 mg/dL for women
- Triglycerides — a separate type of fat carried in the blood; target below 150 mg/dL fasting; very high levels (over 500 mg/dL) need their own treatment plan
- Total cholesterol — a combined number used for general screening; target below 200 mg/dL
- Non-HDL cholesterol — total minus HDL, an increasingly preferred risk marker (AHA 2018) — target below 130 mg/dL general, below 100 mg/dL high-risk
Are There Symptoms? Almost Never — Until There Are
The most important fact about high cholesterol is that it does not produce symptoms in the vast majority of patients. The artery damage accumulates silently over years. The first "symptom" is often a chest pain on exertion (angina), a heart attack, a stroke, or peripheral artery disease. This is why the AHA and USPSTF both treat lipid screening as a routine preventive test rather than a symptom-triggered test.
- Most patients — no symptoms; the only way to know your numbers is a blood test
- Family history of early heart disease (men under 55, women under 65) — the strongest hereditary marker, sometimes a sign of familial hypercholesterolemia
- Xanthelasma — yellowish cholesterol deposits around the eyes — seen in severe or familial cases
- Chest pressure or shortness of breath on exertion — needs urgent evaluation; this is not a screening situation
- Calf pain when walking that resolves with rest — possible peripheral artery disease, related to the same cholesterol biology
Who Should Be Screened — And When
Both the U.S. Preventive Services Task Force and the American Heart Association have moved toward routine adult lipid screening. USPSTF recommends statin therapy for primary prevention in adults age 40 to 75 with one or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater (USPSTF 2022 statin statement). The AHA 2018 cholesterol guideline recommends a baseline lipid panel for adults age 20 and older, then repeating every 4 to 6 years for low-risk adults and more frequently when risk rises.
- Adults age 20 — baseline lipid panel, repeated every 4 to 6 years if low risk (AHA 2018)
- Adults age 40 to 75 with risk factors — calculate 10-year cardiovascular risk; treatment decision based on that number (USPSTF 2022)
- Family history of early heart disease — screen earlier and more often; consider lipoprotein(a) testing
- Diabetes, high blood pressure, smoking, or kidney disease — screen at the time of diagnosis and annually
- Children with strong family history — selective screening starting age 9 to 11 per AAP / AHA
Lifestyle First — How Diet, Exercise, and Weight Change the Numbers
Lifestyle remains the foundation of cholesterol management, even when medication is part of the plan. A well-executed lifestyle change can reduce LDL by 10% to 20% on average, sometimes more. The American Heart Association and AHA 2018 cholesterol guideline both emphasize that lifestyle should be tried first or alongside medication in nearly every patient.
- Dietary pattern — emphasize vegetables, fruits, whole grains, legumes, nuts, fish, olive oil; limit processed meat, ultra-processed foods, and added sugars (Mediterranean-style or DASH pattern)
- Saturated fat — reduce to under 6% of daily calories (AHA recommendation) — biggest single dietary lever on LDL
- Fiber — 25 to 30 g per day, especially soluble fiber (oats, beans, apples, psyllium), can lower LDL 5% to 10%
- Physical activity — 150 minutes per week of moderate aerobic activity (AHA) raises HDL and lowers triglycerides
- Weight — losing 5% to 10% of body weight typically improves all four lipid numbers and lowers cardiovascular risk
- Tobacco cessation — every single ex-smoker's HDL rises within months; smoking is one of the strongest independent cardiovascular risk factors
When Medication Is Recommended — How the Decision Is Made
Whether medication is added is not based on LDL alone — it is based on your overall 10-year cardiovascular risk, calculated using your age, sex, blood pressure, smoking status, diabetes status, and cholesterol numbers (ACC/AHA 2018 Pooled Cohort Equation, refined by the AHA PREVENT calculator in 2023). The AAFP and AHA both endorse a shared-decision-making conversation rather than a one-size-fits-all cutoff. Treatment classes available include statins, ezetimibe-class agents, PCSK9 inhibitors, and bile acid sequestrants. The right class depends on your numbers, risk, kidney and liver function, other medications, and what side effects you are willing to accept.
- 10-year cardiovascular risk below 5% — lifestyle alone is usually appropriate; reassess in 4 to 6 years
- 10-year risk 5% to 7.5% — borderline; lifestyle is the foundation, medication is a conversation
- 10-year risk 7.5% to 20% — moderate; statins are typically discussed and started when shared decision favors
- 10-year risk above 20% or known atherosclerotic disease — statins are strongly recommended; high-intensity dosing when tolerated
- Severe LDL elevation (190 mg/dL or above) — statins recommended regardless of risk calculation
- Specific patient factors — diabetes, age 40 to 75, kidney disease, or family history can shift the decision earlier
Treatment Classes — A Plain-Language Overview
Cholesterol medication is not one drug — it is several distinct classes with different mechanisms. The right class depends on your numbers, your risk, your other conditions, and your tolerance. All decisions about whether and which medication to take should be made with your provider in a real visit; this overview is educational, not a prescription.
- Statins — the most studied lipid class; lower LDL by 30% to 50% and reduce heart attack risk; first-line in almost every guideline (AHA 2018)
- Ezetimibe-class — works in the intestine, often added to statin therapy when LDL is still above target
- PCSK9 inhibitors — injectable, used when LDL stays high on maximum statin therapy or in familial cases
- Bile acid sequestrants — older oral class, used for selected patients including some with mildly elevated LDL who cannot tolerate other options
- Newer agents — additional classes have entered the market for specific situations; your provider will discuss whether they apply to you
Family History and Inherited Cholesterol Disease
Familial hypercholesterolemia (FH) affects roughly 1 in 250 Americans and is dramatically underdiagnosed (CDC, 2024). It is an inherited condition that causes very high LDL cholesterol — often above 190 mg/dL — and a high lifetime risk of early heart disease. If a parent, sibling, or child has early heart disease (under 55 in men, under 65 in women), or if your own LDL is above 190 mg/dL, FH is on the table and the screening conversation should include first-degree relatives.
- Early heart disease in a first-degree relative — strongest single hereditary clue
- Personal LDL above 190 mg/dL — familial hypercholesterolemia screening recommended (AHA 2018)
- Cascade screening — when FH is identified, first-degree relatives (parents, siblings, children) should be tested
- Lipoprotein(a) — a genetic risk factor independent of LDL; tested once in a lifetime per AHA 2021 consensus
- Earlier treatment — FH patients typically need treatment to start younger and reach a stricter LDL target
What to Expect at Your First Cholesterol Visit
A new-patient lipid evaluation in our Doral office is scheduled for 30 to 45 minutes. We collect a careful history, review any past lipid panels you can bring, calculate your individual risk score, and build a plan together — most often with lab orders the same day. Patients on existing medication can usually transfer their care without restarting the workup.
- History (15 min) — family history of heart disease, diet pattern, activity, alcohol, tobacco, current medications, previous lipid panels
- Vitals and exam (10 min) — blood pressure, weight, BMI, abdominal exam, screen for xanthelasma
- Risk calculation — 10-year cardiovascular risk using the ACC/AHA Pooled Cohort Equation or AHA PREVENT calculator
- Lab plan — fasting lipid panel, plus tests like A1C, kidney and liver function, and lipoprotein(a) when indicated
- Plan discussion — clear lifestyle targets, follow-up cadence, and whether medication is part of the conversation
- Follow-up — typically 6 to 12 weeks after starting or adjusting medication, then every 6 to 12 months when stable
Insurance and Bilingual Care
Viva Medical Center is in-network with the major insurance carriers serving Miami-Dade. Lipid panels, follow-up visits, and prescribed treatment fall under your plan's primary care or laboratory benefit. Our front desk verifies your specific plan before the first visit so there are no surprises.
- In-network carriers — Oscar Health, Aetna, Cigna, Humana, Medicare Advantage, Ambetter, UnitedHealthcare
- Self-pay rates available with transparent pricing — no surprise bills
- Bilingual care — intake, visits, telehealth, and patient portal in English and Spanish
- Same-day visits — frequently available; book online or call (305) 209-0001
- Telehealth follow-ups — convenient for lab reviews and stable patients on long-term therapy
Sources
- American Heart Association — About Cholesterol — American Heart Association
- USPSTF — Statin Use for the Primary Prevention of Cardiovascular Disease in Adults (2022) — U.S. Preventive Services Task Force
- NHLBI — High Blood Cholesterol — National Heart, Lung, and Blood Institute (NIH)
- AAFP — Cholesterol Management in Adults — American Academy of Family Physicians
Frequently Asked Questions
What are the symptoms of high cholesterol?
High cholesterol almost never causes symptoms. It builds up silently in artery walls over years, and the first "symptom" is often a chest pain on exertion, a heart attack, a stroke, or leg pain when walking. The only way to know your numbers is a blood test. Family history of early heart disease, xanthelasma (yellow deposits around the eyes), and very high LDL on a screening panel are the closest things to clinical clues, and they are uncommon.
When should I get my cholesterol checked?
The AHA 2018 cholesterol guideline recommends a baseline lipid panel for adults age 20 and older. Low-risk adults can repeat every 4 to 6 years; the USPSTF recommends a more focused approach for adults age 40 to 75 with cardiovascular risk factors. If you have diabetes, high blood pressure, smoke, have kidney disease, or have a family history of early heart disease, screen at diagnosis and then annually. Children with a strong family history can be screened starting age 9 to 11 per AAP and AHA guidance.
What are the LDL and HDL target numbers?
The American Heart Association 2018 cholesterol guideline targets LDL below 100 mg/dL for the general adult population and below 70 mg/dL for adults at high cardiovascular risk. HDL targets are above 40 mg/dL for men and above 50 mg/dL for women. Triglycerides target is below 150 mg/dL fasting. These are population-level targets — your individual target depends on your full cardiovascular risk picture, and your provider will personalize it.
When are medications recommended versus lifestyle alone?
The decision is not based on LDL alone — it is based on your overall 10-year cardiovascular risk. Adults with low risk (under 5%) are usually managed with lifestyle alone. Adults with moderate to high risk (above 7.5%), known cardiovascular disease, diabetes plus risk factors, or LDL above 190 mg/dL are typically offered medication. The USPSTF 2022 statin statement supports medication for adults age 40 to 75 with at least one cardiovascular risk factor and a 10-year risk of 10% or higher. Lifestyle is part of the plan regardless of whether medication is started.
What lifestyle changes actually lower cholesterol?
The evidence-based lifestyle moves are: a Mediterranean-style or DASH dietary pattern, reducing saturated fat to under 6% of daily calories (AHA), increasing soluble fiber to 25 to 30 g per day, 150 minutes per week of moderate aerobic activity (AHA), losing 5% to 10% of body weight if overweight, and stopping tobacco. Done well, lifestyle alone can reduce LDL by 10% to 20%. Lifestyle is the foundation of treatment even when medication is also used.
I am young and feel healthy. Do I really need a cholesterol test?
Yes — the AHA recommends a baseline lipid panel for adults age 20 and older. The number one reason: by the time symptoms appear (chest pain, heart attack), the damage has been accumulating for years. Identifying high cholesterol in your 20s or 30s gives you decades to change the trajectory — when lifestyle alone often works and medication is rarely needed. Identifying it after a heart attack in your 50s is a different conversation.
If my parent had early heart disease, what does that mean for me?
A first-degree relative (parent, sibling, child) with heart disease before age 55 (men) or 65 (women) is the strongest single hereditary clue for high cardiovascular risk and possibly familial hypercholesterolemia (FH). It moves you to earlier and more frequent screening, often a stricter LDL target, and a discussion of lipoprotein(a) — a genetic risk factor tested once in a lifetime per AHA 2021 consensus. We screen first-degree relatives when FH is suspected (cascade screening per CDC guidance).
Are cholesterol medications safe? What about side effects?
All cholesterol medication classes have decades of safety data and well-characterized side-effect profiles. Statins are the most studied — the most common side effect discussion involves muscle aches, which affect a small percentage of patients and can usually be addressed by dose adjustment or switching classes. Liver and kidney function are typically monitored on initiation and at follow-up labs. The decision to take any medication is always a shared one with your provider, weighing your individual risk reduction against the side-effect profile.
Does insurance cover cholesterol testing and treatment?
Yes for our in-network carriers — Oscar Health, Aetna, Cigna, Humana, Medicare Advantage, Ambetter, and UnitedHealthcare. Lipid panels are a routine preventive or diagnostic lab, and follow-up visits fall under the primary care benefit. Most generic cholesterol medications are covered at low copay tiers. Our front desk verifies your specific plan before the first visit. Self-pay rates are available with transparent pricing.
Do you offer bilingual care?
Yes. All services — intake, visits, telehealth follow-ups, lab review, and patient portal communication — are available in English and Spanish. Roughly two-thirds of our patients prefer Spanish, and our entire clinical team is bilingual. We will explain your numbers and treatment plan in whichever language helps you understand them best.